Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helene Thygesen

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|May 19, 2011
Bayesian procedures for phase I/II clinical trials investigating the safety and efficacy of drug combinationsJohn Whitehead, Helene Thygesen, Anne Whitehead
Statistics in Medicine|July 27, 2010
A Bayesian dose-finding procedure for phase I clinical trials based only on the assumption of monotonicityJohn Whitehead, Helene Thygesen, Anne Whitehead
Pharmaceutical Statistics|September 27, 2012
A bivariate Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritisHelene Thygesen, Vladimir Dragalin, Anne Whitehead, et al.
Journal of Biopharmaceutical Statistics|December 31, 2010
Estimation strategies for reacting to the identification of an association between the genome and adverse drug reactionsHelene Thygesen, Ting-Li Su, John Whitehead, et al.
International Journal of Cancer|May 7, 2014
Using common variants to indicate cancer genesLucy F Stead, Helene Thygesen, David R Westhead, et al.
Pharmaceutical Statistics|August 3, 2013
Investigation of the robustness of two models for assessing synergy in pre-clinical drug combination studiesAnne Whitehead, Ting-Li Su, Helene Thygesen, et al.
Pharmaceutical Statistics|March 27, 2015
Experimental designs for detecting synergy and antagonism between two drugs in a pre-clinical studyMatthew Sperrin, Helene Thygesen, Ting-Li Su, et al.
Pharmaceutical Statistics|December 17, 2008
Action following the discovery of a global association between the whole genome and adverse event risk in a clinical drug-development programmeJohn Whitehead, Patrick Kelly, Yinghui Zhou, et al.
Plos One|December 7, 2019
Seasonality of deaths with respect to age and cause in Chitral District PakistanMuhammad Asif, Khalid Nawaz, Zafar Zaheer, et al.
Statistics in Medicine|April 13, 2012
A novel Phase I/IIa design for early phase oncology studies and its application in the evaluation of MK-0752 in pancreatic cancerJohn Whitehead, Helene Thygesen, Thomas Jaki, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|May 19, 2011
Bayesian procedures for phase I/II clinical trials investigating the safety and efficacy of drug combinationsJohn Whitehead, Helene Thygesen, Anne Whitehead
Statistics in Medicine|July 27, 2010
A Bayesian dose-finding procedure for phase I clinical trials based only on the assumption of monotonicityJohn Whitehead, Helene Thygesen, Anne Whitehead
Pharmaceutical Statistics|September 27, 2012
A bivariate Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritisHelene Thygesen, Vladimir Dragalin, Anne Whitehead, et al.
Journal of Biopharmaceutical Statistics|December 31, 2010
Estimation strategies for reacting to the identification of an association between the genome and adverse drug reactionsHelene Thygesen, Ting-Li Su, John Whitehead, et al.
International Journal of Cancer|May 7, 2014
Using common variants to indicate cancer genesLucy F Stead, Helene Thygesen, David R Westhead, et al.
Pharmaceutical Statistics|August 3, 2013
Investigation of the robustness of two models for assessing synergy in pre-clinical drug combination studiesAnne Whitehead, Ting-Li Su, Helene Thygesen, et al.
Pharmaceutical Statistics|March 27, 2015
Experimental designs for detecting synergy and antagonism between two drugs in a pre-clinical studyMatthew Sperrin, Helene Thygesen, Ting-Li Su, et al.
Pharmaceutical Statistics|December 17, 2008
Action following the discovery of a global association between the whole genome and adverse event risk in a clinical drug-development programmeJohn Whitehead, Patrick Kelly, Yinghui Zhou, et al.
Plos One|December 7, 2019
Seasonality of deaths with respect to age and cause in Chitral District PakistanMuhammad Asif, Khalid Nawaz, Zafar Zaheer, et al.
Statistics in Medicine|April 13, 2012
A novel Phase I/IIa design for early phase oncology studies and its application in the evaluation of MK-0752 in pancreatic cancerJohn Whitehead, Helene Thygesen, Thomas Jaki, et al.
Pageof 3